96-week resistance analyses of the STaR study: rilpivirine/emtricitabine/tenofovir DF versus efavirenz/emtricitabine/tenofovir DF in antiretroviral-naive, HIV-1-infected subjects.
HIV clinical trials | 2000-01-01 | PMID 25777187
Porter Danielle P, Kulkarni Rima, Fralich Todd and 2 more
